Pabitra Baran Chatterjee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Pabitra Baran Chatterjee has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
Riya Ghosh
CSIR-Central Salt and Marine Chemicals Research Institute, Bhavnagar, Gujarat-364002, India
14 shared publicationsRatish R. Nair
Analytical & Environmental Science Division and Centralized Instrument Facility, CSIR-CSMCRI, G. B. Marg, Bhavnagar 364002, India
10 shared publications- Snehasish Debnath
Central Salt &Marine Chemicals Research Institute Bhavnagar Gujarat India
10 shared publications Snehasish Debnath
9 shared publicationsDebjani Pradhan
Central Salt &Marine Chemicals Research Institute Bhavnagar Gujarat India
8 shared publicationsM. Raju
Analytical & Environmental Science Division and Centralized Instrument Facility CSIR-CSMCRI, G. B. Marg Bhavnagar India
7 shared publications
Latest Publications
- 29 September 2026
- Published by Royal Society of Chemistry (RSC) in Sustainable Energy & Fuels
- Vol. 10 (19) , 4624-4635
Mn( iii / iv ) incorporated porphyrin-based covalent organic polymer as an efficient bifunctional electrocatalyst for hydrazine oxidation and oxygen reduction reactions
A high-valent Mn( iii / iv ) incorporated porphyrin-based covalent organic polymer has been reported, which demonstrates bifunctional electrocatalytic activity towards the HzOR and ORR in alkaline media.
- 29 September 2026
- Published by Royal Society of Chemistry (RSC) in Sustainable Energy & Fuels
- Vol. 10 (19) , 4624-4635
Mn( iii / iv ) incorporated porphyrin-based covalent organic polymer as an efficient bifunctional electrocatalyst for hydrazine oxidation and oxygen reduction reactions
A high-valent Mn( iii / iv ) incorporated porphyrin-based covalent organic polymer has been reported, which demonstrates bifunctional electrocatalytic activity towards the HzOR and ORR in alkaline media.
- Open Access
- 26 August 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (33) , e74279
A Review of Recent Developments in Organic Probes for the Optical Detection of G‐Series Nerve Gas Simulants
Nerve gases are chemical warfare agents (CWA) that cause irreversible inhibition of acetylcholinesterase in our body and consequently pose prominent lethal threats to the human race. The pragmatic detection and quantification of these harmful chemicals are therefore crucial for timely prevention and protection against such deadly hazards. Conversely, the research and developments related to these toxic gases suffer from serious life risks and are thus kept restricted and confidential among government agencies. A pertinent alternative choice for such R&D schemes therefore utilizes simpler, realistic nerve gas analogues (simulants) that are not only less toxic but also efficiently minimize the potential risk to research personnel. Herein, we present a systematic review on recently developed organic probes designed for the optical detection of nerve gas simulants with a specific focus on G‐series surrogates. The article further collates diverse mechanistic pathways for individual simulant‐probe interactions involving different functional groups in the probe molecules that cause prominent measurable changes in the spectral signature of the probe. Finally, we summarize the promising avenues to deploy faster error‐free nerve gas detections with efficient neutralization of toxic gases and propose revised policies for emergency guidelines to minimize casualties and hence promote global sustainability.
- 26 August 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (33) , e74279
Open AccessA Review of Recent Developments in Organic Probes for the Optical Detection of G‐Series Nerve Gas Simulants
Nerve gases are chemical warfare agents (CWA) that cause irreversible inhibition of acetylcholinesterase in our body and consequently pose prominent lethal threats to the human race. The pragmatic detection and quantification of these harmful chemicals are therefore crucial for timely prevention and protection against such deadly hazards. Conversely, the research and developments related to these toxic gases suffer from serious life risks and are thus kept restricted and confidential among government agencies. A pertinent alternative choice for such R&D schemes therefore utilizes simpler, realistic nerve gas analogues (simulants) that are not only less toxic but also efficiently minimize the potential risk to research personnel. Herein, we present a systematic review on recently developed organic probes designed for the optical detection of nerve gas simulants with a specific focus on G‐series surrogates. The article further collates diverse mechanistic pathways for individual simulant‐probe interactions involving different functional groups in the probe molecules that cause prominent measurable changes in the spectral signature of the probe. Finally, we summarize the promising avenues to deploy faster error‐free nerve gas detections with efficient neutralization of toxic gases and propose revised policies for emergency guidelines to minimize casualties and hence promote global sustainability.
- 17 August 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 55 (16) , 8755-8883
Metalloprobes for gasotransmitters/biothiols linked diseases: innovation-to-implementation
This review provides a comprehensive roadmap of metalloprobes for the precise, real-time monitoring of gasotransmitters and biothiols in complex biological systems, highlighting their transformative potential to advance future disease diagnostics.
- 17 August 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 55 (16) , 8755-8883
Metalloprobes for gasotransmitters/biothiols linked diseases: innovation-to-implementation
This review provides a comprehensive roadmap of metalloprobes for the precise, real-time monitoring of gasotransmitters and biothiols in complex biological systems, highlighting their transformative potential to advance future disease diagnostics.
- 3 March 2026
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 21 (5) , e70659
Advances in the Development of Antibiotic Drug Candidates for Urinary Tract Infection Therapy
Urinary tract infections (UTIs) remain one of the most prevalent bacterial infections worldwide, and their complications are increasingly exacerbated by antibiotic resistance. The predominant pathogen, Escherichia coli ( E. coli) , contributes to both uncomplicated and complicated infections through adhesion and biofilm formation, posing major therapeutic challenges. This review critically examines current and emerging antibiotic drug candidates for UTI therapy, integrating insights from microbiology, clinical studies, and medicinal chemistry. Existing antibiotics for UTI treatment include trimethoprim/sulfamethoxazole, nitrofurantoin, fosfomycin, ciprofloxacin, levofloxacin, cephalexin, ceftriaxone, amoxicillin/clavulanate, doxycycline, and piperacillin/tazobactam. Additionally, Orlynvah and Pivya, two recently approved antibiotics, are discussed for their potential use in UTI therapy. The review also discusses structure‐activity relationship (SAR)‐guided development of trimethoprim derivatives and heterocyclic analogues targeting dihydrofolate reductase (DHFR), with docking and mechanistic studies proposed for future evaluation. Nonantibiotic strategies, such as mannosides, curli inhibitors, and FimH antagonists, are also being explored as promising anti‐adhesion and biofilm‐targeting therapies. This review emphasizes the urgent need for novel, resistance‐resilient antibacterial agents and highlights recent chemical and biological innovations that could transform future UTI prevention and therapy.
- 3 March 2026
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 21 (5) , e70659
Advances in the Development of Antibiotic Drug Candidates for Urinary Tract Infection Therapy
Urinary tract infections (UTIs) remain one of the most prevalent bacterial infections worldwide, and their complications are increasingly exacerbated by antibiotic resistance. The predominant pathogen, Escherichia coli ( E. coli) , contributes to both uncomplicated and complicated infections through adhesion and biofilm formation, posing major therapeutic challenges. This review critically examines current and emerging antibiotic drug candidates for UTI therapy, integrating insights from microbiology, clinical studies, and medicinal chemistry. Existing antibiotics for UTI treatment include trimethoprim/sulfamethoxazole, nitrofurantoin, fosfomycin, ciprofloxacin, levofloxacin, cephalexin, ceftriaxone, amoxicillin/clavulanate, doxycycline, and piperacillin/tazobactam. Additionally, Orlynvah and Pivya, two recently approved antibiotics, are discussed for their potential use in UTI therapy. The review also discusses structure‐activity relationship (SAR)‐guided development of trimethoprim derivatives and heterocyclic analogues targeting dihydrofolate reductase (DHFR), with docking and mechanistic studies proposed for future evaluation. Nonantibiotic strategies, such as mannosides, curli inhibitors, and FimH antagonists, are also being explored as promising anti‐adhesion and biofilm‐targeting therapies. This review emphasizes the urgent need for novel, resistance‐resilient antibacterial agents and highlights recent chemical and biological innovations that could transform future UTI prevention and therapy.
- 6 August 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry A
- Vol. 13 (38) , 32402-32415
Visualizing SO 2 gas via selective adsorption–desorption by an α,β-unsaturated iminium salt
A strategy has been developed to separate SO 2 gas from other toxic gases. The cheletropic reaction between silica-supported α,β-unsaturated iminium salt LI@MOS with SO 2 gas showed reversible adsorption–desorption as high as 20 mmolg −1 .
- 6 August 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry A
- Vol. 13 (38) , 32402-32415
Visualizing SO 2 gas via selective adsorption–desorption by an α,β-unsaturated iminium salt
A strategy has been developed to separate SO 2 gas from other toxic gases. The cheletropic reaction between silica-supported α,β-unsaturated iminium salt LI@MOS with SO 2 gas showed reversible adsorption–desorption as high as 20 mmolg −1 .
- 28 June 2025
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 64 (27) , 13986-13999
Ce and Co Incorporated Covalent Organic Polymer Based on Tetraethylene Glycol-Linked Porphyrin as a Trifunctional Catalyst for Water Splitting and Zn–Air Batteries
- 28 June 2025
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 64 (27) , 13986-13999
Ce and Co Incorporated Covalent Organic Polymer Based on Tetraethylene Glycol-Linked Porphyrin as a Trifunctional Catalyst for Water Splitting and Zn–Air Batteries
- 6 April 2025
- Published by Elsevier in Chemical Engineering Journal
- Vol. 512
NIR emissive dendritic fibrous nanosilica: Ultra-High adsorption and detection of the toxic sarin simulant
- 6 April 2025
- Published by Elsevier in Chemical Engineering Journal
- Vol. 512
NIR emissive dendritic fibrous nanosilica: Ultra-High adsorption and detection of the toxic sarin simulant
A Redox‐Active Copper Complex for Orthogonal Detection of Homocysteine Involving Fluorescence and Electrochemical Techniques
The present work reports the synthesis, characterization, and excited state photo‐physical studies of two copper(II) compounds, 1 & 2, which show interference‐free emission with homocysteine (Hcy). Cu(II) complexes offer an orthogonal detection strategy involving fluorescence and electrochemical methods, paving the way for improved point‐of‐care diagnostics and early cardiovascular diseases intervention. The reduction‐induced emission enhancement (RIEE) of Cu complexes facilitates the fluorescence measurement of Hcy at physiological pH. The fluorogenic redox‐active 1 and 2 are deposited onto gold electrode surfaces to construct the electrochemical sensors 1@Au and 2@Au, respectively. Under specific alkaline conditions, a distinct and selective redox peak at 0.6 V (vs Ag/AgCl) emerges for 1@Au upon interaction with homocysteine. Further, square wave voltammetry confirms the non‐interference of its congener (cysteine) even at high concentrations (200 µM) while detecting Hcy (5–100 µM), demonstrating its potential for real‐world applications. The fabricated 1@Au exhibits excellent sensitivity of 31.88 µA/µM, with an impressive detection limit of 2.26 nM, and a limit of quantification of 6.85 nM toward Hcy. The analytical applicability of the 1@Au is validated by quantifying Hcy levels in human blood plasma samples. The results highlighted the feasibility of the proposed technique as a rapid and portable monitoring of Hcy in diagnosing cardiovascular diseases (CVDs).
A Redox‐Active Copper Complex for Orthogonal Detection of Homocysteine Involving Fluorescence and Electrochemical Techniques
The present work reports the synthesis, characterization, and excited state photo‐physical studies of two copper(II) compounds, 1 & 2, which show interference‐free emission with homocysteine (Hcy). Cu(II) complexes offer an orthogonal detection strategy involving fluorescence and electrochemical methods, paving the way for improved point‐of‐care diagnostics and early cardiovascular diseases intervention. The reduction‐induced emission enhancement (RIEE) of Cu complexes facilitates the fluorescence measurement of Hcy at physiological pH. The fluorogenic redox‐active 1 and 2 are deposited onto gold electrode surfaces to construct the electrochemical sensors 1@Au and 2@Au, respectively. Under specific alkaline conditions, a distinct and selective redox peak at 0.6 V (vs Ag/AgCl) emerges for 1@Au upon interaction with homocysteine. Further, square wave voltammetry confirms the non‐interference of its congener (cysteine) even at high concentrations (200 µM) while detecting Hcy (5–100 µM), demonstrating its potential for real‐world applications. The fabricated 1@Au exhibits excellent sensitivity of 31.88 µA/µM, with an impressive detection limit of 2.26 nM, and a limit of quantification of 6.85 nM toward Hcy. The analytical applicability of the 1@Au is validated by quantifying Hcy levels in human blood plasma samples. The results highlighted the feasibility of the proposed technique as a rapid and portable monitoring of Hcy in diagnosing cardiovascular diseases (CVDs).
- 20 August 2024
- Published by Wiley in Chemistry – A European Journal
- Vol. 30 (50) , e202401255
A Hydrogen Bonded Non‐Porous Organic‐Inorganic Framework for Measuring Cysteine in Blood Plasma and Endogenous Cancer Cell
An imbalance in cysteine (Cys) levels in the cells and plasma has been identified as the risk indicator for various human diseases. The structural similarity of cysteine with its congener homocysteine and glutathione offers challenges in its measurement. Herein, we report a hydrogen‐bonded organic‐inorganic framework of Cu(II) (HOIF) for the selective detection of cysteine over other biothiols. The non‐fluorescent HOIF showed 12‐fold green emission in the presence of cysteine. The monomeric unit of HOIF is stabilized via intermolecular hydrogen bonds, resulting in a non‐porous network structure. Non‐interference from homocysteine, glutathione, and other competitive bio‐analytes revealed explicit affinity of HOIF for cysteine. Fluorimetric titration showed a wide working concentration window (650 nM–800 μM) for measuring cysteine in an aqueous medium. The mechanistic investigation involving HRMS, EPR, and UV‐vis spectroscopic studies revealed the decomplexation of HOIF with Cys, resulting in a fluorescence turn‐on response from the luminescent ligand. Validation using a commercial dye, “Cysteine Green”, confirmed the prospect of HOIF for early diagnostic purposes. Utilizing the fluorescence turn‐on property of HOIF in the presence of cysteine, we measured cysteine quantitatively in the blood plasma samples. Bio‐imaging of endogenous cysteine in cancer cells indicated the ability of HOIF to monitor the intracellular cysteine.
- 20 August 2024
- Published by Wiley in Chemistry – A European Journal
- Vol. 30 (50) , e202401255
A Hydrogen Bonded Non‐Porous Organic‐Inorganic Framework for Measuring Cysteine in Blood Plasma and Endogenous Cancer Cell
An imbalance in cysteine (Cys) levels in the cells and plasma has been identified as the risk indicator for various human diseases. The structural similarity of cysteine with its congener homocysteine and glutathione offers challenges in its measurement. Herein, we report a hydrogen‐bonded organic‐inorganic framework of Cu(II) (HOIF) for the selective detection of cysteine over other biothiols. The non‐fluorescent HOIF showed 12‐fold green emission in the presence of cysteine. The monomeric unit of HOIF is stabilized via intermolecular hydrogen bonds, resulting in a non‐porous network structure. Non‐interference from homocysteine, glutathione, and other competitive bio‐analytes revealed explicit affinity of HOIF for cysteine. Fluorimetric titration showed a wide working concentration window (650 nM–800 μM) for measuring cysteine in an aqueous medium. The mechanistic investigation involving HRMS, EPR, and UV‐vis spectroscopic studies revealed the decomplexation of HOIF with Cys, resulting in a fluorescence turn‐on response from the luminescent ligand. Validation using a commercial dye, “Cysteine Green”, confirmed the prospect of HOIF for early diagnostic purposes. Utilizing the fluorescence turn‐on property of HOIF in the presence of cysteine, we measured cysteine quantitatively in the blood plasma samples. Bio‐imaging of endogenous cysteine in cancer cells indicated the ability of HOIF to monitor the intracellular cysteine.
- 25 April 2024
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 63 (18) , 8320-8328
A Water-Soluble Wavy Coordination Polymer of Cu(II) as a Turn-On Luminescent Probe for Histidine and Histidine-Rich Proteins/Peptides
Histidine plays an essential role in most biological systems. Changes in the homeostasis of histidine and histidine-rich proteins are connected to several diseases. Herein, we report a water-soluble Cu(II) coordination polymer, labeled CuCP, for the fluorimetric detection of histidine and histidine-rich proteins and peptides. Single-crystal structure determination of CuCP revealed a two-dimensional wavy network structure in which a carboxylate group connects the individual Cu(II) dimer unit in a syn-anti conformation. The weakly luminescent and water-soluble CuCP shows turn-on blue emission in the presence of histidine and histidine-rich peptides and proteins. The polymer can also stain histidine-rich proteins via gel electrophoresis. The limits of quantifications for histidine, glycine-histidine, serine-histidine, human serum albumin (HSA), bovine serum albumin, pepsin, trypsin, and lysozyme were found to be 300, 160, 600, 300, 600, 800, 120, and 290 nM, respectively. Utilizing the fluorescence turn-on property of CuCP, we measured HSA quantitatively in the urine samples. We also validated the present urinary HSA measurement assay with existing analytical techniques. Job's plot, 1H NMR, high-resolution mass spectrometry (HRMS), electron paramagnetic resonance (EPR), fluorescence, and UV-vis studies confirmed the ligand displacement from CuCP in the presence of histidine.
- 25 April 2024
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 63 (18) , 8320-8328
A Water-Soluble Wavy Coordination Polymer of Cu(II) as a Turn-On Luminescent Probe for Histidine and Histidine-Rich Proteins/Peptides
Histidine plays an essential role in most biological systems. Changes in the homeostasis of histidine and histidine-rich proteins are connected to several diseases. Herein, we report a water-soluble Cu(II) coordination polymer, labeled CuCP, for the fluorimetric detection of histidine and histidine-rich proteins and peptides. Single-crystal structure determination of CuCP revealed a two-dimensional wavy network structure in which a carboxylate group connects the individual Cu(II) dimer unit in a syn-anti conformation. The weakly luminescent and water-soluble CuCP shows turn-on blue emission in the presence of histidine and histidine-rich peptides and proteins. The polymer can also stain histidine-rich proteins via gel electrophoresis. The limits of quantifications for histidine, glycine-histidine, serine-histidine, human serum albumin (HSA), bovine serum albumin, pepsin, trypsin, and lysozyme were found to be 300, 160, 600, 300, 600, 800, 120, and 290 nM, respectively. Utilizing the fluorescence turn-on property of CuCP, we measured HSA quantitatively in the urine samples. We also validated the present urinary HSA measurement assay with existing analytical techniques. Job's plot, 1H NMR, high-resolution mass spectrometry (HRMS), electron paramagnetic resonance (EPR), fluorescence, and UV-vis studies confirmed the ligand displacement from CuCP in the presence of histidine.